Clinical Trials

Inclusion Criteria:

• Female patients 18 years of age or older.
• Patients must have completed a standard screen for infectious communicable diseases (HPV, Gonorrhea and Chlamydia) as part of their evaluation for symptomatic refractory BV or vaginitis.
  • Women enrolled as normal healthy controls may have completed a standard screen for infectious communicable diseases if clinically indicated (HPV, chlamydia, gonorrhea), although not required for study participation.
• Patient must have undergone standard culture based diagnostics and at least one round of treatment with standard therapies.
• Patient presenting vaginal symptoms commonly associated with BV or vaginitis that is unresponsive to treatment and for which physician has determined that no additional therapy is available.
• Normal, healthy women without a history of bacterial vaginosis will be offered enrollment as controls.

Exclusion Criteria:  

• Women who are pregnant or nursing.
• Vulnerable adults including prisoners, or anyone unable to understand and give informed consent.
• Patient currently taking or have taken antibiotics in the past 2 weeks.
• Women enrolled as normal healthy controls must not have a history of recurrent BV or active symptoms of vaginitis at time of study entry.